| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| Sep 18, 2020 | Sep 23, 2020 | Hardiman Roy C. Chief Business Officer | Sell | $99.98 | $499,918 | -4.01% |
| Aug 18, 2020 | Aug 21, 2020 | Thomas Dolca Chief Medical Officer | Sell | $100 | $2M | -89.15% |
| Aug 18, 2020 | Aug 21, 2020 | Chai Christopher Y CFO | Sell | $99.37 | $745,240 | -52.30% |
| Aug 10, 2020 | Aug 13, 2020 | Goldstein David M Chief Scientific Officer | Sell | $88.61 | $531,665 | -15.90% |
| Jul 15, 2020 | Jul 18, 2020 | Thomas Dolca Chief Medical Officer | Sell | $80.07 | $1M | -89.15% |
| Jul 01, 2020 | Jul 03, 2020 | Colowick Alan Dir | Sell | $60 | $450,000 | -0 |
| Jun 23, 2020 | Jun 26, 2020 | Babler Martin Pres CEO | Sell | $61.86 | $927,889 | -20.45% |
| Jun 15, 2020 | Jun 18, 2020 | Wolff Stefani Chief Development Officer | Sell | $60.75 | $334,385 | -22.37% |
| Mar 16, 2020 | Jun 18, 2020 | Wolff Stefani Chief Development Officer | Sell | $46.15 | $254,031 | -18.28% |
| Dec 16, 2019 | Jun 18, 2020 | Wolff Stefani Chief Development Officer | Sell | $49.43 | $272,091 | -15.46% |
| Jun 12, 2020 | Jun 16, 2020 | Hardiman Roy C. Chief Business Officer | Sell | $61.16 | $305,788 | -4.01% |
| May 19, 2020 | May 22, 2020 | Chai Christopher Y CFO | Sell | $65.1 | $488,268 | -52.30% |
| May 07, 2020 | May 09, 2020 | Goldstein David M Chief Scientific Officer | Sell | $60.16 | $360,941 | -16.23% |
| May 01, 2020 | May 06, 2020 | Colowick Alan Dir | Sell | $60.01 | $450,057 | -0 |
| Mar 16, 2020 | Mar 18, 2020 | Wolff Stefani Chief Development Officer | Sell | $46.15 | $254,031 | -13.39% |
| Mar 13, 2020 | Mar 17, 2020 | Hardiman Roy C. Chief Business Officer | Sell | $48.56 | $242,816 | -4.04% |
| Mar 03, 2020 | Mar 05, 2020 | Babler Martin Pres CEO | Sell | $63.47 | $952,083 | -27.69% |
| Feb 18, 2020 | Feb 20, 2020 | Chai Christopher Y CFO | Sell | $65.89 | $494,186 | -48.18% |
| Feb 10, 2020 | Feb 13, 2020 | Goldstein David Chief Scientific Officer | Sell | $70.9 | $425,400 | -16.23% |
| Dec 19, 2019 | Dec 21, 2019 | Thomas Dolca Chief Medical Officer | Sell | $60 | $29,700 | -50.05% |
| Dec 17, 2019 | Dec 20, 2019 | Babler Martin Pres CEO | Sell | $53.07 | $2M | -61.64% |
| Dec 16, 2019 | Dec 19, 2019 | Wolff Stefani Chief Development Officer | Sell | $49.43 | $272,091 | -13.39% |
| Dec 13, 2019 | Dec 14, 2019 | Hardiman Roy C. Chief Business Officer | Sell | $49.41 | $247,034 | -3.95% |
| Nov 20, 2019 | Nov 23, 2019 | Becker Daniel J. Dir | Buy | $29.94 | $2M | +7.61% |
| Nov 07, 2019 | Nov 09, 2019 | Goldstein David Chief Scientific Officer | Sell | $32.39 | $323,914 | -25.11% |
| Oct 28, 2019 | Oct 30, 2019 | Becker Daniel J. Dir | Buy | $33.48 | $3M | +11.24% |
| Oct 18, 2019 | Oct 22, 2019 | Glaxosmithkline Plc Former 10% Owner | Buy | $28 | $10M | +10.69% |
| Oct 18, 2019 | Oct 22, 2019 | George Simeon Dir | Buy | $28 | $10M | +10.69% |
| Oct 18, 2019 | Oct 22, 2019 | Becker Daniel J. Dir | Buy | $28 | $15M | +50.00% |
| Aug 13, 2019 | Aug 15, 2019 | New Leaf Ventures Ii, L.P. 10% | Sell | $35 | $11M | -43.63% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.